#1
Posted: Wed Feb 04, 2026 12:31 pm
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, or NKT cells—powerful immune cells with a unique ability to infiltrate solid tumors—and systematically compared four targeting systems, called chimeric antigen receptors, or CARs, that direct these cells to attack cancer.
Source: https://medicalxpress.com/news/2026-02- ... ready.html
Source: https://medicalxpress.com/news/2026-02- ... ready.html